A Historical Slowdown: Mertz Taggart’s Q3 2023 Home-Based Care M&A Report

A Historical Slowdown: Mertz Taggart’s Q3 2023 Home-Based Care M&A Report

The latest Home-Based Care M&A Report from Mertz Taggart, a Fort Myers, Florida-based M&A firm, sheds light on the subdued M&A activity in the Home Health & Hospice (HH&H) sectors throughout 2023. While the second quarter showed a slight uptick, Q3 remained slow, raising concerns within the industry. The third quarter witnessed historically low transaction numbers, with only 23 HH&H transactions announced, a 12% decrease from Q2:23, and a 15% decrease from Q3:22, according to data captured in the LevinPro HC database.  One factor contributing to the slowdown could be the anticipation surrounding the home health payment rule, which resulted in a modest 0.8% aggregate... Read More »
Amwins Releases State of the Market Report: A Focus on Healthcare

Amwins Releases State of the Market Report: A Focus on Healthcare

Amwins, a global distributor specializing in insurance products and services, released on November 8 a healthcare-focused State of the Market report. The report offers insights into current market trends, their impact on capacity and pricing and the specific challenges faced by different classes within the healthcare industry.  The Amwins Healthcare State of the Market Report delves into the multitude of factors influencing the healthcare marketplace. It includes detailed insights across critical segments, such as long-term care and senior living facilities, hospitals and non-emergency medical transport (NEMT).  “Current developments are keeping the trajectory of the... Read More »
CVS Health Scores with $2.2 Billion in Q3 Profit Amid Layoffs and Acquisitions

CVS Health Scores with $2.2 Billion in Q3 Profit Amid Layoffs and Acquisitions

CVS Health (NYSE: CVS) released its Q3:23 operating results on Wednesday, November 1, 2023. The company reported net income of $2.2 billion, or $1.75 per share, thanks to double-digit percentage sales growth across all the company’s businesses and contributions from its new healthcare services acquisitions. This compares to the net loss of $3.4 billion, or $2.59 per share, announced in the same quarter last year when the company recorded $5 billion in opioid-related litigation charges. The giant drugstore chain has spent nearly $20 billion this year on acquisitions. First, the company added senior primary care centers via its acquisition of Oak Street Health for $10.6 billion in February.... Read More »
Telemedicine Surge Drives Increased EHR Utilization, New Study From JAMA Reveals

Telemedicine Surge Drives Increased EHR Utilization, New Study From JAMA Reveals

In a recently published report in JAMA Internal Medicine, A. Jay Holmgren, PhD, and colleagues explore the relationship between the increasing adoption of telemedicine and key indicators of electronic health record (EHR) utilization among ambulatory physicians. Over a period of 115 weeks, the study observed 1,052 ambulatory physicians at a major academic medical center, providing a robust dataset of 35,697 physician-week observations. The aim of the study was to investigate how telemedicine utilization influenced physician EHR engagement and patient messaging volume in the ambulatory healthcare setting.  There has been an increase in telehealth M&A this year. While most eHealth... Read More »
Danaher Disappoints with Q3:23 Sales and Profit Decline

Danaher Disappoints with Q3:23 Sales and Profit Decline

Danaher Corp. (NYSE: DHR), a well-known player in the medical device market, recently unveiled its third-quarter financial results on October 24. With a global presence, Danaher specializes in the design, manufacture and distribution of professional, medical, industrial and commercial products and services. The latest earnings report painted a somber picture for Danaher, as the company grappled with a decline in both sales and profits compared to the previous year. This underwhelming performance came as the pharma and biotech sectors experienced a broader loss of momentum in critical markets. “Pharma and biotech took a modest step down, and that was particularly the case in the U.S. In... Read More »
Akumin Files for Bankruptcy to Eliminate $470 Million in Debt

Akumin Files for Bankruptcy to Eliminate $470 Million in Debt

Radiology provider Akumin announced that it has filed for Chapter 11 bankruptcy protection in a bid to eliminate a debt of $470 million, as reported by Radiology Business. Akumin’s approach is to convert this debt into common shares of the company’s stock, which will be owned by their lender, Stonepeak. As part of this restructuring, Akumin will transition from a publicly traded entity to a privately held company, bolstered by an infusion of $130 million in new investment from Stonepeak.  The decision marks the conclusion of a period of financial turmoil for Akumin, which saw the value of its stock plummet by more than 80% in the past year. This crisis was exacerbated by... Read More »